IVIG Treatment Denied by Insurance? How to Appeal
Insurance denied IVIG (intravenous immunoglobulin) therapy? IVIG denials are common for off-label uses — but many are overturned on appeal. Learn the strongest arguments.
Intravenous immunoglobulin (IVIG) is one of the most expensive treatments in modern medicine — a single infusion can cost $5,000 to $20,000 or more. When insurance denies IVIG coverage, the financial impact is immediate and severe. The good news: IVIG denials are among the most successfully appealed treatment denials, particularly when you know how to build the medical record.
What Is IVIG and Why Is It Denied?
IVIG is a blood-derived therapy containing antibodies pooled from thousands of donors. It is used to treat a wide range of immune and neurological conditions — some FDA-approved, many used off-label based on extensive clinical evidence.
Insurance companies deny IVIG for several reasons:
- Off-label use: The insurer's Clinical Policy Bulletin (CPB) does not list your specific condition as a covered indication
- Not medically necessary: The insurer's file reviewer applies an outdated or overly restrictive medical necessity standard
- Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained: The treatment proceeded without the required advance approval
- Frequency exceeds policy limits: You have received more infusions than the plan allows per period
- Alternatives not exhausted: The insurer argues other, less expensive treatments should be tried first
FDA-Approved IVIG Indications: These Should Never Be Denied as Experimental
If your condition falls into one of IVIG's FDA-approved indications, your insurer has no basis to call the treatment experimental or investigational:
- Primary immunodeficiency diseases (PIDD)
- Immune thrombocytopenic purpura (ITP)
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Multifocal motor neuropathy (MMN)
- Kawasaki disease
- Bone marrow transplantation (infection prophylaxis)
- B-cell chronic lymphocytic leukemia (infection prophylaxis)
If your insurer denied IVIG for any of these conditions, cite the FDA approval directly in your appeal and request that the denial be reversed immediately.
Off-Label but Evidence-Based: A Stronger Case Than You Think
IVIG is widely and legitimately used off-label for conditions where clinical evidence strongly supports its use, including:
- Dermatomyositis and polymyositis
- Stiff-person syndrome
- Autoimmune encephalitis (including anti-NMDA receptor encephalitis)
- POEMS syndrome
- Myasthenia gravis (MG)
- Neuromyelitis optica (NMO)
- Guillain-Barre syndrome maintenance
- Pediatric autoimmune neuropsychiatric disorders (PANDAS/PANS)
Off-label does not mean experimental. The standard for insurance coverage is whether the treatment is medically necessary and supported by credible clinical evidence — not whether the FDA has issued a formal label for your specific condition.
How to Build Your IVIG Appeal
Step 1: Get the Insurer's Clinical Policy Bulletin
Request a copy of the insurer's current CPB for IVIG. This is the internal document your insurer used to evaluate your claim. Read the clinical criteria carefully. In many cases, your condition IS listed — but the insurer's reviewer applied the criteria incorrectly or the treating physician's documentation didn't clearly show you met the clinical thresholds. If that's the gap, it can be fixed with better documentation.
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
Step 2: Cite Peer-Reviewed Literature and Specialty Guidelines
If your condition is not listed in the CPB, build an off-label evidence package:
- PubMed-indexed clinical trials and systematic reviews supporting IVIG for your condition
- American Academy of Neurology (AAN) practice guidelines
- American Academy of Allergy, Asthma & Immunology (AAAAI) guidelines
- AABB (formerly American Association of Blood Banks) IVIG use guidelines
- Subspecialty society position statements relevant to your diagnosis
Your treating specialist (neurologist, immunologist, rheumatologist) should provide a detailed letter citing specific literature and explaining why your case meets or exceeds the evidence threshold.
Step 3: Request an External Independent Review: Complete Guide" class="auto-link">External Review
External IROs) Explained" class="auto-link">independent review organizations (IROs) are required by the ACA for most US health plans. IRO physicians are typically subspecialists who are more current on emerging evidence than an insurer's file reviewer. External review is especially powerful for IVIG because independent physicians familiar with the relevant specialty literature often reverse CPB-based denials.
Step 4: Arrange a Peer-to-Peer Call
A direct peer-to-peer call between your treating neurologist or immunologist and the insurer's medical director is often the fastest path to reversal for IVIG denials. The insurer's medical director may not specialize in your condition — your physician's direct explanation of disease severity, urgency, and lack of alternatives carries weight that a written record sometimes does not.
Step 5: Document Clinical Urgency
If delayed treatment poses a serious risk of irreversible harm — neurological deterioration, disease progression, hospitalization — document this explicitly in your appeal. Urgency strengthens the medical necessity argument and may qualify you for expedited review.
Documentation Checklist
- Insurance denial letter (all pages)
- Insurer's Clinical Policy Bulletin for IVIG (request from insurer)
- ICD-10 diagnosis codes from treating physician
- Specialist's detailed letter documenting: diagnosis, disease severity, prior treatments tried and failed, clinical rationale for IVIG
- Relevant lab values, imaging, or neurological testing results
- Peer-reviewed studies supporting IVIG for your specific condition (print and attach)
- Specialty society guidelines (AAN, AAAAI, AABB as applicable)
- Documentation of alternative treatments tried and failed (with dates and outcomes)
- Prior authorization records (if applicable)
- External review request (if internal appeal is denied)
Fight Back With ClaimBack
ClaimBack analyzes your IVIG denial and helps you build a medical necessity appeal grounded in the specific evidence that overturns this type of denial.
Start your free IVIG appeal at ClaimBack
Free analysis · No credit card required · Takes 3 minutes
Related Reading
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides